# Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease

> **NCT03720418** · PHASE1,PHASE2 · TERMINATED · sponsor: **Sio Gene Therapies** · enrollment: 6 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** OXB-102
- **OTHER:** Imitation Surgical Procedure (ISP)

## Key facts

- **NCT ID:** NCT03720418
- **Lead sponsor:** Sio Gene Therapies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-17
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-04-12
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** As a result of termination of development of OXB-102-01, it is no longer possible for Sio to either commence or to continue any related clinical trials.
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03720418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03720418, "Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03720418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*